These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 35578355

  • 1. Golden bifid might improve diarrhea-predominant irritable bowel syndrome via microbiota modulation.
    Luo M, Liu Q, Xiao L, Xiong LS.
    J Health Popul Nutr; 2022 May 16; 41(1):21. PubMed ID: 35578355
    [Abstract] [Full Text] [Related]

  • 2. Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly Prevotella abundance.
    Wu KQ, Sun WJ, Li N, Chen YQ, Wei YL, Chen DF.
    Scand J Gastroenterol; 2019 Dec 16; 54(12):1419-1425. PubMed ID: 31765575
    [Abstract] [Full Text] [Related]

  • 3. Fecal Microbiota Alterations Associated With Diarrhea-Predominant Irritable Bowel Syndrome.
    Zhuang X, Tian Z, Li L, Zeng Z, Chen M, Xiong L.
    Front Microbiol; 2018 Dec 16; 9():1600. PubMed ID: 30090090
    [Abstract] [Full Text] [Related]

  • 4. Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.
    Yang M, Zhang L, Hong G, Li Y, Li G, Qian W, Xiong H, Bai T, Song J, Hou X.
    J Gastroenterol Hepatol; 2020 May 16; 35(5):795-805. PubMed ID: 31674052
    [Abstract] [Full Text] [Related]

  • 5. Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome.
    Li Y, Hong G, Yang M, Li G, Jin Y, Xiong H, Qian W, Hou X.
    Pharmacol Res; 2020 Sep 16; 159():104936. PubMed ID: 32470562
    [Abstract] [Full Text] [Related]

  • 6. The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors.
    Lin H, Guo Q, Wen Z, Tan S, Chen J, Lin L, Chen P, He J, Wen J, Chen Y.
    Microb Cell Fact; 2021 Dec 28; 20(1):233. PubMed ID: 34963452
    [Abstract] [Full Text] [Related]

  • 7. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
    Liu ZJ, Wei H, Duan LP, Zhu SW, Zhang L, Wang K.
    Zhonghua Yi Xue Za Zhi; 2016 Jun 28; 96(24):1896-902. PubMed ID: 27373356
    [Abstract] [Full Text] [Related]

  • 8. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T, Hausken T, Hov JR, Valeur J, Sangnes DA, El-Salhy M, Gilja OH, Hatlebakk JG, Lied GA.
    Scand J Gastroenterol; 2019 Jun 28; 54(6):690-699. PubMed ID: 31190584
    [Abstract] [Full Text] [Related]

  • 9. Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome.
    Zhuang X, Tian Z, Luo M, Xiong L.
    BMC Gastroenterol; 2020 Jun 12; 20(1):187. PubMed ID: 32532214
    [Abstract] [Full Text] [Related]

  • 10. Altered metabolism of bile acids correlates with clinical parameters and the gut microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Wei W, Wang HF, Zhang Y, Zhang YL, Niu BY, Yao SK.
    World J Gastroenterol; 2020 Dec 07; 26(45):7153-7172. PubMed ID: 33362374
    [Abstract] [Full Text] [Related]

  • 11. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Maharshak N, Ringel Y, Katibian D, Lundqvist A, Sartor RB, Carroll IM, Ringel-Kulka T.
    Dig Dis Sci; 2018 Jul 07; 63(7):1890-1899. PubMed ID: 29777439
    [Abstract] [Full Text] [Related]

  • 12. [The dietary features of diarrhea predominant irritable bowel syndrome patients with small intestinal bowel overgrowth].
    Wei H, Liu ZJ, Wang K, Zheng W, Duan LP.
    Zhonghua Nei Ke Za Zhi; 2017 Aug 01; 56(8):567-571. PubMed ID: 28789488
    [Abstract] [Full Text] [Related]

  • 13. The effect of fecal microbiota transplantation on psychiatric symptoms among patients with irritable bowel syndrome, functional diarrhea and functional constipation: An open-label observational study.
    Kurokawa S, Kishimoto T, Mizuno S, Masaoka T, Naganuma M, Liang KC, Kitazawa M, Nakashima M, Shindo C, Suda W, Hattori M, Kanai T, Mimura M.
    J Affect Disord; 2018 Aug 01; 235():506-512. PubMed ID: 29684865
    [Abstract] [Full Text] [Related]

  • 14. Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot Study.
    Bustos Fernández LM, Man F, Lasa JS.
    Dig Dis; 2023 Aug 01; 41(5):798-809. PubMed ID: 36630947
    [Abstract] [Full Text] [Related]

  • 15. Gut microbial signatures of patients with diarrhea-predominant irritable bowel syndrome and their healthy relatives.
    Chen J, Lan H, Li C, Xie Y, Cheng X, Xia R, Ke C, Liang X.
    J Appl Microbiol; 2024 Jun 03; 135(6):. PubMed ID: 38849305
    [Abstract] [Full Text] [Related]

  • 16. [Effect of Tiaoshen Jianpi acupuncture therapy on gut microbiota and fecal short-chain fatty acids in patients with diarrhea type irritable bowel syndrome].
    Chen L, Xu WL, Pei LX, Wu XL, Geng H, Guo J, Sun JH.
    Zhongguo Zhen Jiu; 2021 Feb 12; 41(2):137-41. PubMed ID: 33788460
    [Abstract] [Full Text] [Related]

  • 17. Involvement of mucosal flora and enterochromaffin cells of the caecum and descending colon in diarrhoea-predominant irritable bowel syndrome.
    Yang J, Wang P, Liu T, Lin L, Li L, Kou G, Zhou R, Li P, Li Y.
    BMC Microbiol; 2021 Nov 13; 21(1):316. PubMed ID: 34773967
    [Abstract] [Full Text] [Related]

  • 18. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B, Mun Jung S, Hwan Choi C, Song ID, Woong Lee H, Joon Kim H, Hyuk J, Kyung Chang S, Kim K, Chung WS, Seo JG.
    J Clin Gastroenterol; 2012 Mar 13; 46(3):220-7. PubMed ID: 22157240
    [Abstract] [Full Text] [Related]

  • 19. The effect of Clostridium butyricum on symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Sun YY, Li M, Li YY, Li LX, Zhai WZ, Wang P, Yang XX, Gu X, Song LJ, Li Z, Zuo XL, Li YQ.
    Sci Rep; 2018 Feb 14; 8(1):2964. PubMed ID: 29445178
    [Abstract] [Full Text] [Related]

  • 20. Baseline gut microbial profiles are associated with the efficacy of Bacillus subtilis and Enterococcus faecium in IBS-D.
    Hong G, Li Y, Yang M, Li G, Jin Y, Xiong H, Qian W, Hou X.
    Scand J Gastroenterol; 2023 Apr 14; 58(4):339-348. PubMed ID: 36281578
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.